chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Headache, Vertigo
Clinical narrative: Dizziness; Vertigo; Dull Headaches; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizziness), VERTIGO (Vertigo) and HEADACHE (Dull Headaches) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Jan-2021, the patient experienced HEADACHE (Dull Headaches). On 06-Feb-2021, the patient experienced DIZZINESS (Dizziness) and VERTIGO (Vertigo). The patient was treated with MECLIZINE [MECLOZINE] ongoing since an unknown date for Vertigo, at an unspecified dose and frequency. At the time of the report, DIZZINESS (Dizziness), VERTIGO (Vertigo) and HEADACHE (Dull Headaches) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Headache, Myalgia, Pruritus
Clinical narrative: Redness; Itchiness on arm; body aches; Headache; A spontaneous report was received from a consumer concerning a 67-years-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events body aches, redness, itchiness on arm, headache.  The patient's medical history was not provided. Concomitant medications reported were Aleve, Aspirin for drug use for unknown indication.  On 25 Feb 2021, prior to the onset of the events the patient received first of two planned doses of mRNA-1273 (lot/batch: unknown) intramuscularly for prophylaxis of COVID-19 infection.  On 26 Feb 2021, the patient experienced the event(s) body aches, redness, itchiness on arm, headache.  No treatment information was provided.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of event(s), body aches, redness, itchiness on arm, headache was unknown.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea
Clinical narrative: Severe diarrhea; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (Severe diarrhea) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001A21A) for COVID-19 vaccination. No Medical History information was reported. On 23-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Feb-2021, the patient experienced DIARRHOEA (Severe diarrhea). At the time of the report, DIARRHOEA (Severe diarrhea) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment medication include Imodium chloride.
Sex: F
Vaccine: COVID19
Symptoms: Urinary tract infection
Clinical narrative: Urinary tract infection; This spontaneous case was reported by a consumer and describes the occurrence of URINARY TRACT INFECTION (Urinary tract infection) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 immunisation.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Mar-2021, the patient experienced URINARY TRACT INFECTION (Urinary tract infection). At the time of the report, URINARY TRACT INFECTION (Urinary tract infection) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were provided. Treatment medications were unknown.  The patient was prone to UTI's.
Age: 44.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, Pharyngeal swelling, Vomiting
Clinical narrative: Swollen throat; Severe headache; Vomiting; This spontaneous case was reported by a consumer and describes the occurrence of PHARYNGEAL SWELLING (Swollen throat), HEADACHE (Severe headache) and VOMITING (Vomiting) in a 44-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history reported).   On 01-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Mar-2021, the patient experienced PHARYNGEAL SWELLING (Swollen throat), HEADACHE (Severe headache) and VOMITING (Vomiting). At the time of the report, PHARYNGEAL SWELLING (Swollen throat), HEADACHE (Severe headache) and VOMITING (Vomiting) outcome was unknown.            No concomitant information was reported. Treatment information was not reported.
Age: 50.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: soreness at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (soreness at the injection site) in a 50-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 02-Mar-2021, the patient experienced VACCINATION SITE PAIN (soreness at the injection site). At the time of the report, VACCINATION SITE PAIN (soreness at the injection site) outcome was unknown.            No concomitant medications were reported. No treatment medication was reported.   The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was Not applicable.
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Injection site rash, Rash
Clinical narrative: rashes; rep / pink rash on the inside of the injection forearm; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE RASH (rashes) and RASH (rep / pink rash on the inside of the injection forearm) in a 74-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036A21A) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 22-Mar-2021, the patient experienced INJECTION SITE RASH (rashes) and RASH (rep / pink rash on the inside of the injection forearm). At the time of the report, INJECTION SITE RASH (rashes) and RASH (rep / pink rash on the inside of the injection forearm) outcome was unknown.
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Induration, Ocular discomfort, Pain in extremity
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of OCULAR DISCOMFORT (eye discomfort), PAIN IN EXTREMITY (soreness on her arm), INDURATION (hardness on her arm), FATIGUE (fatigue chills hardness on her arm a high fever) and PYREXIA (fever) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. The patient's past medical history included No adverse event (no medical history was reported.). On 01-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Mar-2021, the patient experienced INDURATION (hardness on her arm), FATIGUE (fatigue chills hardness on her arm a high fever), PYREXIA (fever) and CHILLS (chills). On 02-Mar-2021, the patient experienced OCULAR DISCOMFORT (eye discomfort) and PAIN IN EXTREMITY (soreness on her arm). At the time of the report, OCULAR DISCOMFORT (eye discomfort), PAIN IN EXTREMITY (soreness on her arm), INDURATION (hardness on her arm), FATIGUE (fatigue chills hardness on her arm a high fever), PYREXIA (fever) and CHILLS (chills) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. Treatment details included Tylenol. Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of OCULAR DISCOMFORT (eye discomfort), PAIN IN EXTREMITY (soreness on her arm), INDURATION (hardness on her arm), FATIGUE (fatigue chills hardness on her arm a high fever) and PYREXIA (fever) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. The patient's past medical history included No adverse event (no medical history was reported.). On 01-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Mar-2021, the patient experienced INDURATION (hardness on her arm), FATIGUE (fatigue chills hardness on her arm a high fever), PYREXIA (fever) and CHILLS (chills). On 02-Mar-2021, the patient experienced OCULAR DISCOMFORT (eye discomfort) and PAIN IN EXTREMITY (soreness on her arm). At the time of the report, OCULAR DISCOMFORT (eye discomfort), PAIN IN EXTREMITY (soreness on her arm), INDURATION (hardness on her arm), FATIGUE (fatigue chills hardness on her arm a high fever), PYREXIA (fever) and CHILLS (chills) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. Treatment details included Tylenol. Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Sex: U
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: freezer temperature went from 5 F to 6.4 F for 6 minutes; A spontaneous report was received from a healthcare professional regarding a patient of an unspecified age and gender who received Moderna's COVID-19 vaccine (mRNA-1273). No adverse event was reported after the administration of the vaccine. It was known that the freezer temperature went above 5 degrees Fahrenheit to 6.4 degrees Fahrenheit for about 6 minutes and went back to 5 degrees Fahrenheit affecting 49 vaccine vials.   The patient's medical history was not provided. No concomitant product use was reported.  On 02 Mar 2021, the patient received their first of two planned doses of mRNA-1273 (Lot number: 026L20A) intramuscularly for prophylaxis of COVID-19 infection. On 02-Mar-2021, it was known that the freezer temperature went above 5 degrees Fahrenheit to 6.4 degrees Fahrenheit for about 6 minutes and went back to 5 degrees Fahrenheit impacting 49 vials. Of the 49 vials, 35 vials were used and 14 vials were left in the freezer at a temperature of 5 degrees Fahrenheit. No change in physical appearance was reported and all the 14 vials were frozen.  Treatment information was not applicable.  Action taken with mRNA-1273 was unknown.   The outcome of the event, freezer temperature went above 5 degrees Fahrenheit to 6.4 degrees Fahrenheit for about 6 minutes, is not applicable.; Reporter's Comments: This report refers to a case of Product storage error for mRNA-1273, lot # 026L20A with no associated AEs.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal discomfort, Fatigue, Pain in extremity, Pyrexia, Vaccination site pain
Clinical narrative: Pain in the Left Arm; Upset Stomach; Tired; Fever100.6 F; Pain on the Injection Site; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Pain in the Left Arm), ABDOMINAL DISCOMFORT (Upset Stomach), VACCINATION SITE PAIN (Pain on the Injection Site), FATIGUE (Tired) and PYREXIA (Fever100.6 F) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Feb-2021, the patient experienced VACCINATION SITE PAIN (Pain on the Injection Site). On 09-Feb-2021, the patient experienced PAIN IN EXTREMITY (Pain in the Left Arm), ABDOMINAL DISCOMFORT (Upset Stomach), FATIGUE (Tired) and PYREXIA (Fever100.6 F). On 16-Feb-2021, PAIN IN EXTREMITY (Pain in the Left Arm), ABDOMINAL DISCOMFORT (Upset Stomach), VACCINATION SITE PAIN (Pain on the Injection Site), FATIGUE (Tired) and PYREXIA (Fever100.6 F) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided. Treatment medications were unknown.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Nausea, Pain, Pyrexia
Clinical narrative: Body Ache; Nausea; Chills; Possible Fever; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Body Ache), NAUSEA (Nausea), CHILLS (Chills) and PYREXIA (Possible Fever) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Feb-2021, the patient experienced PAIN (Body Ache), NAUSEA (Nausea), CHILLS (Chills) and PYREXIA (Possible Fever). The patient was treated with PARACETAMOL (TYLENOL) ongoing since an unknown date at an unspecified dose and frequency. At the time of the report, PAIN (Body Ache), NAUSEA (Nausea), CHILLS (Chills) and PYREXIA (Possible Fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events,   a causal relationship cannot be excluded.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Headache, Influenza, Malaise
Clinical narrative: Felt really sick; Flu; Chills; Vomiting; Headache; Pain in every joint in body; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (Felt really sick), INFLUENZA (Flu), CHILLS (Chills), VOMITING (Vomiting) and HEADACHE (Headache) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 from September 2020 to October 2020. Concurrent medical conditions included Blood pressure high and Anxiety.    On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Mar-2021, the patient experienced MALAISE (Felt really sick), INFLUENZA (Flu), CHILLS (Chills), VOMITING (Vomiting), HEADACHE (Headache) and ARTHRALGIA (Pain in every joint in body). At the time of the report, MALAISE (Felt really sick), INFLUENZA (Flu), CHILLS (Chills), VOMITING (Vomiting), HEADACHE (Headache) and ARTHRALGIA (Pain in every joint in body) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications included Blood pressure and Anxiety medications. Treatment medications were unknown.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Vomiting
Clinical narrative: Felt really sick; Flu; Chills; Vomiting; Headache; Pain in every joint in body; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (Felt really sick), INFLUENZA (Flu), CHILLS (Chills), VOMITING (Vomiting) and HEADACHE (Headache) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 from September 2020 to October 2020. Concurrent medical conditions included Blood pressure high and Anxiety.    On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Mar-2021, the patient experienced MALAISE (Felt really sick), INFLUENZA (Flu), CHILLS (Chills), VOMITING (Vomiting), HEADACHE (Headache) and ARTHRALGIA (Pain in every joint in body). At the time of the report, MALAISE (Felt really sick), INFLUENZA (Flu), CHILLS (Chills), VOMITING (Vomiting), HEADACHE (Headache) and ARTHRALGIA (Pain in every joint in body) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications included Blood pressure and Anxiety medications. Treatment medications were unknown.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Asthenia, Fatigue, Headache, Myalgia
Clinical narrative: I felt itchy; Felt generally weak; Muscle ache; Rash on the elbow/Rash under the arm/Rash across the stomach/Rash on inner part of the thighs; Sore thighs; Very tired/ extremely tired; Sore shoulders/Sore knees/Sore ankles; Bad headache; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore thighs), PRURITUS (I felt itchy), ASTHENIA (Felt generally weak), MYALGIA (Muscle ache) and FATIGUE (Very tired/ extremely tired) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 012A21A and 004M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Previously administered products included for an unreported indication: Codeine (Patient experienced itching after codeine.). Past adverse reactions to the above products included Itching with Codeine.   On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 25-Feb-2021, the patient experienced PAIN IN EXTREMITY (Sore thighs), FATIGUE (Very tired/ extremely tired), ARTHRALGIA (Sore shoulders/Sore knees/Sore ankles) and HEADACHE (Bad headache). On 26-Feb-2021, the patient experienced RASH (Rash on the elbow/Rash under the arm/Rash across the stomach/Rash on inner part of the thighs). On an unknown date, the patient experienced PRURITUS (I felt itchy), ASTHENIA (Felt generally weak) and MYALGIA (Muscle ache). The patient was treated with PARACETAMOL (TYLENOL EXTRA STRENGTH) ongoing since an unknown date for Adverse event, at an unspecified dose and frequency and IBUPROFEN ongoing since an unknown date for Adverse event, at an unspecified dose and frequency. On 02-Mar-2021, RASH (Rash on the elbow/Rash under the arm/Rash across the stomach/Rash on inner part of the thighs) had resolved. At the time of the report, PAIN IN EXTREMITY (Sore thighs), PRURITUS (I felt itchy), ASTHENIA (Felt generally weak), MYALGIA (Muscle ache), FATIGUE (Very tired/ extremely tired), ARTHRALGIA (Sore shoulders/Sore knees/Sore ankles) and HEADACHE (Bad headache) had resolved.            Patient was taking allergy shots since November 2020 twice a week and currently on a maintenance program.  Patient was broke out in rash twice about a day after injection. Rash was clear in a day or two and patient had no itching after rash broke out.   Most recent FOLLOW-UP information incorporated above includes: On 06-Jul-2021: No new information received On 13-Jul-2021: Significant follow up appended
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Pruritus, Rash
Clinical narrative: I felt itchy; Felt generally weak; Muscle ache; Rash on the elbow/Rash under the arm/Rash across the stomach/Rash on inner part of the thighs; Sore thighs; Very tired/ extremely tired; Sore shoulders/Sore knees/Sore ankles; Bad headache; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore thighs), PRURITUS (I felt itchy), ASTHENIA (Felt generally weak), MYALGIA (Muscle ache) and FATIGUE (Very tired/ extremely tired) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 012A21A and 004M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Previously administered products included for an unreported indication: Codeine (Patient experienced itching after codeine.). Past adverse reactions to the above products included Itching with Codeine.   On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 25-Feb-2021, the patient experienced PAIN IN EXTREMITY (Sore thighs), FATIGUE (Very tired/ extremely tired), ARTHRALGIA (Sore shoulders/Sore knees/Sore ankles) and HEADACHE (Bad headache). On 26-Feb-2021, the patient experienced RASH (Rash on the elbow/Rash under the arm/Rash across the stomach/Rash on inner part of the thighs). On an unknown date, the patient experienced PRURITUS (I felt itchy), ASTHENIA (Felt generally weak) and MYALGIA (Muscle ache). The patient was treated with PARACETAMOL (TYLENOL EXTRA STRENGTH) ongoing since an unknown date for Adverse event, at an unspecified dose and frequency and IBUPROFEN ongoing since an unknown date for Adverse event, at an unspecified dose and frequency. On 02-Mar-2021, RASH (Rash on the elbow/Rash under the arm/Rash across the stomach/Rash on inner part of the thighs) had resolved. At the time of the report, PAIN IN EXTREMITY (Sore thighs), PRURITUS (I felt itchy), ASTHENIA (Felt generally weak), MYALGIA (Muscle ache), FATIGUE (Very tired/ extremely tired), ARTHRALGIA (Sore shoulders/Sore knees/Sore ankles) and HEADACHE (Bad headache) had resolved.            Patient was taking allergy shots since November 2020 twice a week and currently on a maintenance program.  Patient was broke out in rash twice about a day after injection. Rash was clear in a day or two and patient had no itching after rash broke out.   Most recent FOLLOW-UP information incorporated above includes: On 06-Jul-2021: No new information received On 13-Jul-2021: Significant follow up appended
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Maternal exposure during pregnancy, Pregnancy test
Clinical narrative: Pregnancy; This spontaneous prospective pregnancy case was reported by a physician and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (Pregnancy) in a 32-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 030L20A and 025J20-2A) for COVID-19 vaccination.     Concurrent medical conditions included Sleep disorder. Concomitant products included PRENATAL MULTIVITAMIN + DHA from November 2021 to an unknown date for Pregnancy, MELATONIN from January 2020 to an unknown date for Sleep disorder.   On 22-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Jan-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. The patient's last menstrual period was on an unknown date and the estimated date of delivery was 30-Oct-2021. On 22-Dec-2020, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (Pregnancy). On 22-Jan-2021, MATERNAL EXPOSURE DURING PREGNANCY (Pregnancy) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 02-Mar-2021, Pregnancy test: positive (Positive) Positive.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Most recent FOLLOW-UP information incorporated above includes: On 14-Mar-2021: Follow-up information received on 16-Jun-2021 contains updated information of patient demographics, contact information, current condition, pregnancy details, first dose details and concomitant medications.
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Erythema, Feeling hot, Gout, Pain
Clinical narrative: Greatly exacerbated gout flare; Pain; Swelling; Redness; Hot to touch; Fluid build up in his left knee; Arm sensitivity; Increased left knee pain; This spontaneous case was reported by a consumer and describes the occurrence of GOUT (Greatly exacerbated gout flare), PAIN (Pain), SWELLING (Swelling), ERYTHEMA (Redness) and FEELING HOT (Hot to touch) in a 76-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Gout flare (Moderate) from 20-Feb-2021 to 13-Mar-2021. Concurrent medical conditions included Gout since 2010, Asthma since 1980, Psoriasis since 1950, Kidney function abnormal (Reduced kidney function.) since 1970, Osteo arthritis knees (Increased left knee pain) since 2000, Wood dust allergy, Grass allergy, Pollen allergy, Dust allergy and Allergy to animal dander (Cat dander.). Concomitant products included APIUM GRAVEOLENS SEED, BROMELAINS, CURCUMA LONGA ROOT, POTASSIUM CITRATE, PRUNUS SEROTINA FRUIT (GO OUT PLEX) for Gout flare, ZYFLAMEND for Inflammation, VITAMIN D3, PROBIOTICS NOS and VITAMIN B COMPLEX for an unknown indication.    On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Feb-2021, the patient experienced PAIN (Pain), SWELLING (Swelling), ERYTHEMA (Redness), FEELING HOT (Hot to touch), SYNOVIAL DISORDER (Fluid build up in his left knee), VACCINATION SITE PAIN (Arm sensitivity) and ARTHRALGIA (Increased left knee pain). On 26-Feb-2021, the patient experienced GOUT (Greatly exacerbated gout flare). The patient was treated with PREDNISONE (oral) on 01-Mar-2021 for Gout flare, at a dose of Day 4: 20 mg.day 5 :15 mg, day 6 and 7 :10 mg, day 8:7.5 mg and day 9: 2.5 mg. On 13-Mar-2021, GOUT (Greatly exacerbated gout flare) had resolved. At the time of the report, PAIN (Pain), SWELLING (Swelling), ERYTHEMA (Redness), FEELING HOT (Hot to touch), SYNOVIAL DISORDER (Fluid build up in his left knee), VACCINATION SITE PAIN (Arm sensitivity) and ARTHRALGIA (Increased left knee pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       On 02-Apr-2021 at 1:30 PM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) (batch no. 031A21A) for dosage on left upper arm.   Most recent FOLLOW-UP information incorporated above includes: On 02-May-2021: Follow up received on 02-May-2021 contains added patient demographics, medical history and concomitants, treatment, added vaccine information and added event.The outcome of the event gout changed from unknown to recovered.
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Swelling, Synovial disorder, Vaccination site pain
Clinical narrative: Greatly exacerbated gout flare; Pain; Swelling; Redness; Hot to touch; Fluid build up in his left knee; Arm sensitivity; Increased left knee pain; This spontaneous case was reported by a consumer and describes the occurrence of GOUT (Greatly exacerbated gout flare), PAIN (Pain), SWELLING (Swelling), ERYTHEMA (Redness) and FEELING HOT (Hot to touch) in a 76-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Gout flare (Moderate) from 20-Feb-2021 to 13-Mar-2021. Concurrent medical conditions included Gout since 2010, Asthma since 1980, Psoriasis since 1950, Kidney function abnormal (Reduced kidney function.) since 1970, Osteo arthritis knees (Increased left knee pain) since 2000, Wood dust allergy, Grass allergy, Pollen allergy, Dust allergy and Allergy to animal dander (Cat dander.). Concomitant products included APIUM GRAVEOLENS SEED, BROMELAINS, CURCUMA LONGA ROOT, POTASSIUM CITRATE, PRUNUS SEROTINA FRUIT (GO OUT PLEX) for Gout flare, ZYFLAMEND for Inflammation, VITAMIN D3, PROBIOTICS NOS and VITAMIN B COMPLEX for an unknown indication.    On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Feb-2021, the patient experienced PAIN (Pain), SWELLING (Swelling), ERYTHEMA (Redness), FEELING HOT (Hot to touch), SYNOVIAL DISORDER (Fluid build up in his left knee), VACCINATION SITE PAIN (Arm sensitivity) and ARTHRALGIA (Increased left knee pain). On 26-Feb-2021, the patient experienced GOUT (Greatly exacerbated gout flare). The patient was treated with PREDNISONE (oral) on 01-Mar-2021 for Gout flare, at a dose of Day 4: 20 mg.day 5 :15 mg, day 6 and 7 :10 mg, day 8:7.5 mg and day 9: 2.5 mg. On 13-Mar-2021, GOUT (Greatly exacerbated gout flare) had resolved. At the time of the report, PAIN (Pain), SWELLING (Swelling), ERYTHEMA (Redness), FEELING HOT (Hot to touch), SYNOVIAL DISORDER (Fluid build up in his left knee), VACCINATION SITE PAIN (Arm sensitivity) and ARTHRALGIA (Increased left knee pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       On 02-Apr-2021 at 1:30 PM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) (batch no. 031A21A) for dosage on left upper arm.   Most recent FOLLOW-UP information incorporated above includes: On 02-May-2021: Follow up received on 02-May-2021 contains added patient demographics, medical history and concomitants, treatment, added vaccine information and added event.The outcome of the event gout changed from unknown to recovered.
Sex: U
Vaccine: COVID19
Symptoms: Pyrexia, Vaccination site reaction
Clinical narrative: fever; reaction; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (fever) and VACCINATION SITE REACTION (reaction) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PYREXIA (fever) and VACCINATION SITE REACTION (reaction). At the time of the report, PYREXIA (fever) and VACCINATION SITE REACTION (reaction) outcome was unknown.            This case was linked to MOD-2021-031890, MOD-2021-032177 (Patient Link).
Age: 83.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site swelling
Clinical narrative: Swelling at the injection site after the first dose; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE SWELLING (Swelling at the injection site after the first dose) in an 83-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 16-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 16-Jan-2021, the patient experienced VACCINATION SITE SWELLING (Swelling at the injection site after the first dose). At the time of the report, VACCINATION SITE SWELLING (Swelling at the injection site after the first dose) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Concomitant Medications were reported. No treatment was reported.   This case was linked to MOD-2021-032264 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 29-Apr-2021: Follow up received on 29-APR-2021. No new information was reported.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site rash, Vaccination site swelling
Clinical narrative: Swelling in arm below injection site; Red on arm; Rash on arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE SWELLING (Swelling in arm below injection site), VACCINATION SITE ERYTHEMA (Red on arm) and VACCINATION SITE RASH (Rash on arm) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011m2da) for COVID-19 vaccination.     No medical history was provided by the reporter. .  Concomitant products included METFORMIN and VITAMINS NOS for an unknown indication.    On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Feb-2021, the patient experienced VACCINATION SITE SWELLING (Swelling in arm below injection site), VACCINATION SITE ERYTHEMA (Red on arm) and VACCINATION SITE RASH (Rash on arm). At the time of the report, VACCINATION SITE SWELLING (Swelling in arm below injection site), VACCINATION SITE ERYTHEMA (Red on arm) and VACCINATION SITE RASH (Rash on arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Other concomitant product included medications for blood pressure. Treatment information was not provided.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Erythema, Feeling abnormal, Hypertension, Influenza like illness
Clinical narrative: terrible time with her arm, swelling was so bad; pain in her arm; weakness; can't brush her teeth; very red; pain go to her hands and fingers; hot to touch; Feel like arthritis; extremely pain; Blood pressure was high 182; like a flu symptoms; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (terrible time with her arm, swelling was so bad), PAIN IN EXTREMITY (pain in her arm), ASTHENIA (weakness), LIMB DISCOMFORT (can't brush her teeth) and ERYTHEMA (very red) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 024M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Complex regional pain syndrome and Blood pressure. Concomitant products included PARACETAMOL (TYLENOL), PREGABALIN (LYRICA) and METHADONE for an unknown indication.    On 17-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Feb-2021, the patient experienced INFLUENZA LIKE ILLNESS (like a flu symptoms). On an unknown date, the patient experienced PERIPHERAL SWELLING (terrible time with her arm, swelling was so bad), PAIN IN EXTREMITY (pain in her arm), ASTHENIA (weakness), LIMB DISCOMFORT (can't brush her teeth), ERYTHEMA (very red), PAIN IN EXTREMITY (pain go to her hands and fingers), SKIN WARM (hot to touch), FEELING ABNORMAL (Feel like arthritis), PAIN (extremely pain) and HYPERTENSION (Blood pressure was high 182). At the time of the report, PERIPHERAL SWELLING (terrible time with her arm, swelling was so bad), PAIN IN EXTREMITY (pain in her arm), ASTHENIA (weakness), LIMB DISCOMFORT (can't brush her teeth), ERYTHEMA (very red), PAIN IN EXTREMITY (pain go to her hands and fingers), SKIN WARM (hot to touch), FEELING ABNORMAL (Feel like arthritis), INFLUENZA LIKE ILLNESS (like a flu symptoms), PAIN (extremely pain) and HYPERTENSION (Blood pressure was high 182) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medications reported were high blood pressure for drug use for unknown indication. Treatment medication were not provided.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Limb discomfort, Pain, Pain in extremity, Peripheral swelling, Skin warm
Clinical narrative: terrible time with her arm, swelling was so bad; pain in her arm; weakness; can't brush her teeth; very red; pain go to her hands and fingers; hot to touch; Feel like arthritis; extremely pain; Blood pressure was high 182; like a flu symptoms; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (terrible time with her arm, swelling was so bad), PAIN IN EXTREMITY (pain in her arm), ASTHENIA (weakness), LIMB DISCOMFORT (can't brush her teeth) and ERYTHEMA (very red) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 024M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Complex regional pain syndrome and Blood pressure. Concomitant products included PARACETAMOL (TYLENOL), PREGABALIN (LYRICA) and METHADONE for an unknown indication.    On 17-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Feb-2021, the patient experienced INFLUENZA LIKE ILLNESS (like a flu symptoms). On an unknown date, the patient experienced PERIPHERAL SWELLING (terrible time with her arm, swelling was so bad), PAIN IN EXTREMITY (pain in her arm), ASTHENIA (weakness), LIMB DISCOMFORT (can't brush her teeth), ERYTHEMA (very red), PAIN IN EXTREMITY (pain go to her hands and fingers), SKIN WARM (hot to touch), FEELING ABNORMAL (Feel like arthritis), PAIN (extremely pain) and HYPERTENSION (Blood pressure was high 182). At the time of the report, PERIPHERAL SWELLING (terrible time with her arm, swelling was so bad), PAIN IN EXTREMITY (pain in her arm), ASTHENIA (weakness), LIMB DISCOMFORT (can't brush her teeth), ERYTHEMA (very red), PAIN IN EXTREMITY (pain go to her hands and fingers), SKIN WARM (hot to touch), FEELING ABNORMAL (Feel like arthritis), INFLUENZA LIKE ILLNESS (like a flu symptoms), PAIN (extremely pain) and HYPERTENSION (Blood pressure was high 182) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medications reported were high blood pressure for drug use for unknown indication. Treatment medication were not provided.
Age: 81.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Arm is sore at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Arm is sore at the injection site) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Feb-2021, the patient experienced VACCINATION SITE PAIN (Arm is sore at the injection site). At the time of the report, VACCINATION SITE PAIN (Arm is sore at the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were provided. No treatment information was provided.
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Product administration error
Clinical narrative: Possibly had the vaccine run down her arm during administration; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT ADMINISTRATION ERROR (Possibly had the vaccine run down her arm during administration) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038K20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history).    On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Feb-2021, the patient experienced PRODUCT ADMINISTRATION ERROR (Possibly had the vaccine run down her arm during administration). On 03-Feb-2021, PRODUCT ADMINISTRATION ERROR (Possibly had the vaccine run down her arm during administration) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.; Reporter's Comments: This report refers to a case of  Product administration error and Vaccine Underdose for mRNA-1273, (lot #  038K20A) with no associated AEs.
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Rhinorrhoea, Sinusitis, Tinnitus
Clinical narrative: ringing in ears; sinus infection; runny nose and ears were blocked a little; This spontaneous case was reported by a consumer and describes the occurrence of TINNITUS (ringing in ears), SINUSITIS (sinus infection) and RHINORRHOEA (runny nose and ears were blocked a little) in a 70-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016M20A) for COVID-19 vaccination.     The patient's past medical history included Sinus infection.    On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Feb-2021, the patient experienced TINNITUS (ringing in ears), SINUSITIS (sinus infection) and RHINORRHOEA (runny nose and ears were blocked a little). At the time of the report, TINNITUS (ringing in ears), SINUSITIS (sinus infection) and RHINORRHOEA (runny nose and ears were blocked a little) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication details was reported. No treatment medication details was reported. Upon follow up information received on 16 JUL 2021, reported stated that after received the first dose of Moderna vaccine patient experienced ringing in the left ear and hesitant to get the second dose. They have been seen a specialist but it did not help the patient, and that after a year they were getting better.   Most recent FOLLOW-UP information incorporated above includes: On 02-Mar-2021: Narrative was updated.
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Paraesthesia, Pruritus
Clinical narrative: My chin started to feel numb; My chin started to feel itchy; This spontaneous case was reported by a consumer and describes the occurrence of PARAESTHESIA (My chin started to feel numb) and PRURITUS (My chin started to feel itchy) in a 49-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011A21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (Medical history not provided).    On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Mar-2021, the patient experienced PARAESTHESIA (My chin started to feel numb) and PRURITUS (My chin started to feel itchy). At the time of the report, PARAESTHESIA (My chin started to feel numb) and PRURITUS (My chin started to feel itchy) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       This case was linked to MOD-2021-032226 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 09-Apr-2021: No new information was provided.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling hot, Induration, Pruritus, Rash erythematous, Vaccination site reaction
Clinical narrative: Red Rash on the entire upper left arm; COVID arm; Hot to the touch (Left upper arm); Itching Left Upper Arm; Hard to the touch (Left upper arm); This spontaneous case was reported by a consumer and describes the occurrence of RASH ERYTHEMATOUS (Red Rash on the entire upper left arm), VACCINATION SITE REACTION (COVID arm), FEELING HOT (Hot to the touch (Left upper arm)), PRURITUS (Itching Left Upper Arm) and INDURATION (Hard to the touch (Left upper arm)) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Feb-2021, the patient experienced RASH ERYTHEMATOUS (Red Rash on the entire upper left arm), VACCINATION SITE REACTION (COVID arm), FEELING HOT (Hot to the touch (Left upper arm)), PRURITUS (Itching Left Upper Arm) and INDURATION (Hard to the touch (Left upper arm)). On 23-Feb-2021, RASH ERYTHEMATOUS (Red Rash on the entire upper left arm), VACCINATION SITE REACTION (COVID arm), FEELING HOT (Hot to the touch (Left upper arm)), PRURITUS (Itching Left Upper Arm) and INDURATION (Hard to the touch (Left upper arm)) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication details was reported. No treatment medication details was reported.
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Pain in arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Pain in arm) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Feb-2021, the patient experienced PAIN IN EXTREMITY (Pain in arm). At the time of the report, PAIN IN EXTREMITY (Pain in arm) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided.